SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-003464
Filing Date
2021-08-12
Accepted
2021-08-12 16:31:11
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 30, 2021 xenetic_i10q-063021.htm   iXBRL 10-Q 576263
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9906
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 9709
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4822
  Complete submission text file 0001683168-21-003464.txt   2721792

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20210630.xsd EX-101.SCH 23716
6 XBRL CALCULATION FILE xbio-20210630_cal.xml EX-101.CAL 29171
7 XBRL DEFINITION FILE xbio-20210630_def.xml EX-101.DEF 127765
8 XBRL LABEL FILE xbio-20210630_lab.xml EX-101.LAB 185294
9 XBRL PRESENTATION FILE xbio-20210630_pre.xml EX-101.PRE 158038
10 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-063021_htm.xml XML 304750
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 211168068
SIC: 2834 Pharmaceutical Preparations